Latest News

Advocacy Articles

Filter by:
Topic
Clear filter
HOPA logo
Advocacy

HOPA Signs Letters Defending Medicaid, NIH, and More Against Funding Cuts

July 02, 2025

HOPA has joined forces with multiple national health organizations to speak out against proposed cuts to Medicaid, the NIH, and the future of optimized cancer care.

oncology pharmacist at work with patients
Advocacy

Time to Complete Oncology Pharmacist Tasks: A Joint Opinion of HOPA and American College of Clinical Pharmacy's Hematology/Oncology Practice and Research Network

May 28, 2025

HOPA and the Hematology/Oncology Practice and Research Network (PRN) of the ACCP published research producing the first comprehensive consensus statements on the average time for a U.S.-based oncology pharmacist to complete common care-related tasks.

HOPA logo
Advocacy

Together We Can Save Cancer Research - and Lives

May 27, 2025

In the past two decades, extraordinary progress has been made in the fight against cancer. However, with Congress determined to reduce federal spending, entire cancer research, prevention, and surveillance programs are on the verge of elimination.

Advocacy

HOPA Signs Letter in Support of Cancer Research Funding and Infrastructure

February 21, 2025

Thirty-three organizations have signed a letter in support of cancer research funding amid Executive Orders that threaten the stability of research infrastructure.

CanerBuddy app
Advocacy Collaborations

HOPA, Bone Marrow & Cancer Foundation, and Walgreens Specialty Unite to Provide Oncology Pharmacy Education

February 07, 2025

HOPA, the Bone Marrow & Cancer Foundation (BMCF), and Walgreens Specialty Pharmacy have partnered on digital outreach resources and tools to support patients who are navigating the complexities of cancer treatment.

Advocacy

HOPA and CMRignite Launch "Time to Talk Diversity in Clinical Trials" Campaign

November 04, 2024

HOPA and CMRignite have collaborated on "Time to Talk Diversity in Clinical Trials," a campaign to address the critical need for increased diversity in cancer clinical research and ensure that all patient populations are adequately represented.

Advocacy

Pharmacists & Patients Lend Their Voices to Virtual Hill Day

May 07, 2024

HOPA members, patients, and caregivers participated in a total of 80 meetings with representatives from 31 states.

Advocacy

HOPA Supports Pharmacists, Hopes for Workplace Conditions that Optimize Patient Care

October 25, 2023

The pharmacy profession is experiencing unprecedented rates of burnout and good-faith and timely talks are key to swift and satisfactory workforce negotiations.

Advocacy

Oncology Experts Join Together to Provide Best Possible Care for Adolescents and Young Adults with Cancer

May 23, 2023

The Hematology/Oncology Pharmacy Association (HOPA) has partnered with Stupid Cancer, the leader in young adult cancer advocacy, research, and support, to develop tools for healthcare providers who serve the adolescent and young adult (AYA) patient commun

Advocacy

Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey

May 16, 2023

The survey was developed by the HOPA Practice Outcomes and Professional Benchmarking Committee (POPBC) and distributed between March 2021 and January 2022

Pharmacist talking to a customer
Advocacy

The Value of Oncology Pharmacists Op-Ed

August 01, 2022

With Drug Shortages and Errors on the Rise, Oncology Pharmacists are Vital to Navigate Treatment in the Era of a Pandemic

Pharmacist talking to a customer
Advocacy

The Role of the Pharmacist after Dobbs v. Jackson Women’s Health Organization Ruling

July 06, 2022

The Hematology/Oncology Pharmacy Association (HOPA) is committed to optimizing cancer care for all individuals. The recent U.S. Supreme Court decision, which overturned Roe v. Wade, imposes a significant barrier to the oncology community’s ability to ens